You are here

Europe

British data study says COVID-19 vaccines sharply cut hospitalizations

 

LONDON (AP) — Two U.K. studies released Monday showed that COVID-19 vaccination programs are contributing to a sharp drop in hospitalizations, boosting hopes that the shots will work as well in the real world as they have in carefully controlled studies.

Preliminary results from a study in Scotland found that the Pfizer-BioNTech vaccine reduced hospital admissions by up to 85% four weeks after the first dose, while the Oxford-AstraZeneca shot cut admissions by up to 94%. In England, preliminary data from a study of health care workers showed that the Pfizer vaccine reduced the risk of catching COVID-19 by 70% after one dose, a figure that rose to 85% after the second.

 

“This new evidence shows that the jab protects you, and protects those around you,” U.K. Health Secretary Matt Hancock said. “It is important that we see as much evidence as possible on the vaccine’s impact on protection and on transmission and we will continue to publish evidence as we gather it.’’

Problem, Solution, SitRep, or ?: 

EU makes deals to get more vaccines, plans to tackle variants

BRUSSELS (AP) — Amid signs that more infectious coronavirus variants are spreading unchecked across Europe, governments and EU leaders scrambled Wednesday to speed up vaccine efforts that have been hampered by limited supplies and to fund ways to hunt down variants and counter them.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

UK’s Kent virus variant becoming more resistant, could spread, scientists warn

LONDON — The dominant coronavirus variant in the U.K. is becoming more resistant to vaccines, scientific experts have warned.

Two leading scientists in the U.K. warned Wednesday that the variant of the virus first identified in Kent has acquired the same E484K mutation on its spike protein that makes the South Africa variant so worrying for experts.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Europe
howdy folks